Veeva Systems and Sarah Cannon Research Institute Forge Strategic Alliance to Enhance Oncology Trials

As part of this collaboration, SCRI will adopt the Veeva Clinical Platform, which will serve as a cohesive system to unify its contract research organization (CRO) and site management organization (SMO). This integration is designed to create seamless data flow among clinical teams and research sites, thereby enhancing the operational efficiencies of clinical trials.

Yazhene Krishnaraj, Chief Information and Digital Officer at SCRI, expressed enthusiasm about the collaboration, stating, "We are thrilled to advance our clinical trials by integrating Veeva Clinical Platform into our digital toolkit. This strategic collaboration empowers our clinical teams to deliver groundbreaking therapies to patients with enhanced precision and speed."

The Veeva Clinical Platform is set to simplify and standardize trial processes and information flow, improving collaboration between investigators and clinical teams. With a robust and connected foundation for clinical research, SCRI will be able to automate key processes, ultimately providing a streamlined experience for its research sites.

Jim Reilly, President of Veeva Development Cloud, emphasized the innovative nature of this partnership. "We're excited to work closely with SCRI to drive innovation in oncology research," he said. "In a first-of-a-kind partnership, Veeva Clinical Platform will serve as SCRI's clinical trial foundation for its CRO and SMO. By standardizing operations on one platform, we can support SCRI in delivering faster and more cost-effective trials."

The Veeva Clinical Platform is an all-encompassing solution for clinical operations and data applications. It includes essential components such as Clinical Trial Management System (CTMS), Electronic Data Capture (EDC), clinical workbench (CDB), Randomization and Trial Supply Management (RTSM), electronic Clinical Outcome Assessment (eCOA), electronic Trial Master File (eTMF), Site Connect, Study Training, and more. This connected ecosystem streamlines clinical trials from study initiation to closure, facilitating an automated data flow that enhances overall trial efficiency.

SCRI is recognized as one of the world's leading oncology research organizations, specializing in community-based clinical trials. With a rich history spanning over three decades, SCRI has conducted more than 850 first-in-human clinical trials, significantly contributing to the development of new cancer therapies approved by the FDA in the past decade. Its extensive research network includes over 1,300 physicians who enroll patients in clinical trials across more than 20 states in the U.S.

Veeva Systems stands as a premier provider of cloud software tailored for the life sciences industry. Dedicated to innovation, product excellence, and customer success, Veeva serves a diverse clientele that ranges from the largest biopharmaceutical companies to emerging biotech firms. As a Public Benefit Corporation, Veeva emphasizes a commitment to balancing stakeholder interests, including those of customers, employees, shareholders, and the broader industry.

In summary, the partnership between Veeva Systems and Sarah Cannon Research Institute marks a pivotal moment in the evolution of oncology clinical trials, promising enhanced operational efficiencies and accelerated delivery of innovative therapies to patients. This collaboration not only exemplifies the power of technology in advancing medical research but also sets the stage for improved patient outcomes in the fight against cancer.